Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

As Of June 30, 2024, Gyre Therapeutics Had Cash And Cash Equivalents Of $16.1M, Short-term Bank Deposits Of $9M, And Long-term Certificates Of Deposit Of $28.8M. Based On Current Plans, Gyre Anticipates That Its Cash Resources Will Enable It To Fund Operations Through At Least 12 Months

Author: Benzinga Newsdesk | August 13, 2024 06:05am

Posted In: GYRE